Search research articles
Contact Us
Filters
Showing results (191-200 of 436) with videos related to
Page
of 44
Sort By:
American Journal of Hematology
|
August 18, 2020
Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations
Curtis Lachowiez, Sarah Bannon, Sanam Loghavi, et al.
Frontiers in Oncology
|
May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
Alessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Leukemia & Lymphoma
|
September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia
Yue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Leukemia & Lymphoma
|
October 4, 2017
Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting
Prajwal Boddu, Abdul Rashid Shah, Gautam Borthakur, et al.
Leukemia & Lymphoma
|
February 19, 2026
Ten-year long-term survivors of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Amritpal Singh, Naval Daver, Sanam Loghavi, et al.
American Journal of Hematology
|
February 22, 2021
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia
Naval Daver, Amandeep Salhotra, Joseph M Brandwein, et al.
British Journal of Haematology
|
October 15, 2014
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis
Naval Daver, Hagop Kantarjian, Guido Marcucci, et al.
Leukemia & Lymphoma
|
January 18, 2018
Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia
Prajwal Boddu, Hagop Kantarjian, Farhad Ravandi, et al.
Leukemia Research
|
May 14, 2024
Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated MDS and MDS/MPN
Guillermo Montalban-Bravo, Elias Jabbour, Kelly Chien, et al.
American Journal of Hematology
|
April 6, 2022
Prediction of survival with intensive chemotherapy in acute myeloid leukemia
Koji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Page
of 44
Search research articles
Search
Showing results (191-200 of 436) with videos related to
Sort By:
Page
of 44
American Journal of Hematology
|
August 18, 2020
Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations
Curtis Lachowiez, Sarah Bannon, Sanam Loghavi, et al.
Frontiers in Oncology
|
May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
Alessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Leukemia & Lymphoma
|
September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia
Yue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Leukemia & Lymphoma
|
October 4, 2017
Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting
Prajwal Boddu, Abdul Rashid Shah, Gautam Borthakur, et al.
Leukemia & Lymphoma
|
February 19, 2026
Ten-year long-term survivors of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Amritpal Singh, Naval Daver, Sanam Loghavi, et al.
American Journal of Hematology
|
February 22, 2021
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia
Naval Daver, Amandeep Salhotra, Joseph M Brandwein, et al.
British Journal of Haematology
|
October 15, 2014
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis
Naval Daver, Hagop Kantarjian, Guido Marcucci, et al.
Leukemia & Lymphoma
|
January 18, 2018
Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia
Prajwal Boddu, Hagop Kantarjian, Farhad Ravandi, et al.
Leukemia Research
|
May 14, 2024
Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated MDS and MDS/MPN
Guillermo Montalban-Bravo, Elias Jabbour, Kelly Chien, et al.
American Journal of Hematology
|
April 6, 2022
Prediction of survival with intensive chemotherapy in acute myeloid leukemia
Koji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Page
of 44